Research graph
References from Metabolic Alterations in Blood and Saliva During the First Two Cycles of Adjuvant Chemotherapy Correlate with 5-FU Dose Reduction Requirement in Patients with Colorectal Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2024 · External reference
10.1016/0277-5379(90)90188-y
10.1016/0277-5379(90)90188-y · 1990 · External reference
10.1200/jco.2011.38.0915
10.1200/jco.2011.38.0915 · 2012 · External reference
10.1007/s00280-014-2553-2
10.1007/s00280-014-2553-2 · 2014 · External reference
10.1093/annonc/mdl284
10.1093/annonc/mdl284 · 2006 · External reference
10.1016/j.clon.2006.08.005
10.1016/j.clon.2006.08.005 · 2006 · External reference
10.1007/s00280-020-04173-2
10.1007/s00280-020-04173-2 · 2021 · External reference
10.1002/cncr.26595
10.1002/cncr.26595 · 2012 · External reference
10.1002/1097-0142(19950101)75:1<11::aid-cncr2820750104>3.0.co;2-n
10.1002/1097-0142(19950101)75:1<11::aid-cncr2820750104>3.0.co;2-n · 1995 · External reference
Unresolved reference
2010 · External reference
10.1023/a:1006416410198
10.1023/a:1006416410198 · 2000 · External reference
10.1038/s41416-023-02517-2
10.1038/s41416-023-02517-2 · 2024 · External reference
10.1016/j.critrevonc.2023.104061
10.1016/j.critrevonc.2023.104061 · 2023 · External reference
10.1186/s12986-017-0233-z
10.1186/s12986-017-0233-z · 2017 · External reference
10.1177/1721727x0300100205
10.1177/1721727x0300100205 · 2003 · External reference
10.3390/nu13093229
10.3390/nu13093229 · 2021 · External reference
10.3390/pharmaceutics11050199
10.3390/pharmaceutics11050199 · 2019 · External reference
10.2217/pme-2022-0042
10.2217/pme-2022-0042 · 2023 · External reference
Unresolved reference
2002 · External reference
10.3390/cancers15010258
10.3390/cancers15010258 · 2022 · External reference
10.1038/s12276-019-0216-4
10.1038/s12276-019-0216-4 · 2019 · External reference
10.1093/eurjpc/zwae022
10.1093/eurjpc/zwae022 · 2024 · External reference
Unresolved reference
2011 · External reference
10.1097/cad.0000000000000220
10.1097/cad.0000000000000220 · 2015 · External reference
10.2174/1573403x19666230209111854
10.2174/1573403x19666230209111854 · 2023 · External reference
10.1016/j.ajcnut.2025.05.029
10.1016/j.ajcnut.2025.05.029 · 2025 · External reference
10.1016/j.arr.2018.10.010
10.1016/j.arr.2018.10.010 · 2019 · External reference
10.3390/jcm14092998
10.3390/jcm14092998 · 2025 · External reference
Unresolved reference
1998 · External reference
10.5152/ucd.2014.2653
10.5152/ucd.2014.2653 · 2014 · External reference
10.1038/bjc.2017.94
10.1038/bjc.2017.94 · 2017 · External reference
10.3390/ph18050653
10.3390/ph18050653 · 2025 · External reference
10.1007/s00280-025-04851-z
10.1007/s00280-025-04851-z · 2025 · External reference
10.1016/j.esmoop.2024.104002
10.1016/j.esmoop.2024.104002 · 2024 · External reference
10.1002/1097-0142(19950101)75:1<11::aid-cncr2820750104>3.0.co;2-n
10.1002/1097-0142(19950101)75:1<11::aid-cncr2820750104>3.0.co;2-n · ExternalCitation · doi-reference
10.1002/cncr.26595
10.1002/cncr.26595 · ExternalCitation · doi-reference
10.1007/s00280-014-2553-2
10.1007/s00280-014-2553-2 · ExternalCitation · doi-reference
10.1007/s00280-020-04173-2
10.1007/s00280-020-04173-2 · ExternalCitation · doi-reference
10.1007/s00280-025-04851-z
10.1007/s00280-025-04851-z · ExternalCitation · doi-reference
10.1016/0277-5379(90)90188-y
10.1016/0277-5379(90)90188-y · ExternalCitation · doi-reference
10.1016/j.ajcnut.2025.05.029
10.1016/j.ajcnut.2025.05.029 · ExternalCitation · doi-reference
10.1016/j.arr.2018.10.010
10.1016/j.arr.2018.10.010 · ExternalCitation · doi-reference
10.1016/j.clon.2006.08.005
10.1016/j.clon.2006.08.005 · ExternalCitation · doi-reference
10.1016/j.critrevonc.2023.104061
10.1016/j.critrevonc.2023.104061 · ExternalCitation · doi-reference
10.1016/j.esmoop.2024.104002
10.1016/j.esmoop.2024.104002 · ExternalCitation · doi-reference
10.1023/a:1006416410198
10.1023/a:1006416410198 · ExternalCitation · doi-reference
10.1038/bjc.2017.94
10.1038/bjc.2017.94 · ExternalCitation · doi-reference
10.1038/s12276-019-0216-4
10.1038/s12276-019-0216-4 · ExternalCitation · doi-reference
10.1038/s41416-023-02517-2
10.1038/s41416-023-02517-2 · ExternalCitation · doi-reference
10.1093/annonc/mdl284
10.1093/annonc/mdl284 · ExternalCitation · doi-reference
10.1093/eurjpc/zwae022
10.1093/eurjpc/zwae022 · ExternalCitation · doi-reference
10.1097/cad.0000000000000220
10.1097/cad.0000000000000220 · ExternalCitation · doi-reference
10.1177/1721727x0300100205
10.1177/1721727x0300100205 · ExternalCitation · doi-reference
10.1186/s12986-017-0233-z
10.1186/s12986-017-0233-z · ExternalCitation · doi-reference
10.1200/jco.2011.38.0915
10.1200/jco.2011.38.0915 · ExternalCitation · doi-reference
10.2174/1573403x19666230209111854
10.2174/1573403x19666230209111854 · ExternalCitation · doi-reference
10.2217/pme-2022-0042
10.2217/pme-2022-0042 · ExternalCitation · doi-reference
10.3390/cancers15010258
10.3390/cancers15010258 · ExternalCitation · doi-reference
10.3390/jcm14092998
10.3390/jcm14092998 · ExternalCitation · doi-reference
10.3390/nu13093229
10.3390/nu13093229 · ExternalCitation · doi-reference
10.3390/ph18050653
10.3390/ph18050653 · ExternalCitation · doi-reference
10.3390/pharmaceutics11050199
10.3390/pharmaceutics11050199 · ExternalCitation · doi-reference
10.5152/ucd.2014.2653
10.5152/ucd.2014.2653 · ExternalCitation · doi-reference
